ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00726466
Recruitment Status : Withdrawn (Lack of recruitment)
First Posted : August 1, 2008
Last Update Posted : July 7, 2015
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Vitreous -Retina- Macula Consultants of New York

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given